The effect of long-term olive-oil based parenteral lipid use on immune functions: a patient-control study

The effect of long-term olive-oil based parenteral lipid use on immune functions: a patient-control study - Immune modulation by parenteral olive-oil

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON32714

Enrollment

Registered

2008-10-16

Start date

2009-03-01

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

immune modulation by lipids

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: view page 11 of the protocol

Exclusion criteria

Exclusion criteria: view page 11 of the protocol

Design outcomes

Primary

Measure	Time frame
Leukocyte counts (with leukocyte differentiation) Leukocyte functions: oxygenradical production by neutrophils expression of neutrophil and monocyte cell surface activation markers Bacterial killing capacity of neutrophils stimulus-induced ex-vivo cytokineproduction by PBMCs Candidagrowth in cel-free serum (anti-)oxidant status (Vitamin A,C, E, Selenium, glutathion) oxidatieve damage (TBARS (indicative for lipid-peroxidation) and protein carbonyls (indicative for protein damage)	—

Measure

Time frame

Leukocyte counts (with leukocyte differentiation) Leukocyte functions: *oxygenradical production by neutrophils *expression of neutrophil and monocyte cell surface activation markers *Bacterial killing capacity of neutrophils *stimulus-induced ex-vivo cytokineproduction by PBMCs Candidagrowth in cel-free serum (anti-)oxidant status (Vitamin A,C, E, Selenium, glutathion) oxidatieve damage (TBARS (indicative for lipid-peroxidation) and protein carbonyls (indicative for protein damage)

—

Secondary

Measure	Time frame
none	—

Countries

Netherlands

Outcome results